Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers

03 Oct 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077

15 Aug 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077

02 Feb 2022
// E. Sagonowsky FIERCEPHARMA
https://www.fiercepharma.com/pharma/novartis-amgen-settle-their-dueling-lawsuits-over-migraine-drug-aimovig

09 Nov 2021
// Anna Begley EUROPEANPHARMACEUTICALREVIEW
https://www.europeanpharmaceuticalreview.com/news/165242/aimovigdisplays-superiority-over-topiramate-in-migraine-study/

29 Sep 2021
// Angus Liu FIERCEPHARMA
https://www.fiercepharma.com/pharma/abbvie-pressures-biohaven-migraine-prevention-fda-approval-for-cgrp-blockbuster-to-be

20 Aug 2021
// Annalee Armstrong FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/migraine-market-better-make-way-for-abbvie-as-oral-preventative-treatment-atogepant-poised
Global Sales Information
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 326,938,686
Year : 2023
Prescribers : 55770
Prescriptions : 333200

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 302,037,671
Year : 2022
Prescribers : 55228
Prescriptions : 325457

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 258,924,035
Year : 2021
Prescribers : 54670
Prescriptions : 330843

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 206,119,545
Year : 2020
Prescribers : 47870
Prescriptions : 285011

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 56,756
Year : 2020
Prescribers : 67
Prescriptions : 115

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 119,459,268
Year : 2019
Prescribers : 36038
Prescriptions : 169428

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 11,334,892
Year : 2019
Prescribers : 7828
Prescriptions : 18101

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 12,485,893
Year : 2018
Prescribers : 8254
Prescriptions : 17481

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Amgen
Erenumab-Aooe
Drug Cost (USD) : 6,163,955
Year : 2018
Prescribers : 4790
Prescriptions : 9917

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Solution for injection in a pre-...
Dosage Strength : 70 mg/ml
Price Per Pack (Euro) : 217.86
Published in :
Country : Norway
RX/OTC/DISCN :

Novartis Europharm Limited (1)
Dosage Form : Solution for injection in a pre-...
Dosage Strength : 140 mg/ml
Price Per Pack (Euro) : 217.86
Published in :
Country : Norway
RX/OTC/DISCN :

Dosage Form : Solution for injection in a pre-...
Dosage Strength : 70 mg/ml
Price Per Pack (Euro) : 217.86
Published in :
Country : Norway
RX/OTC/DISCN :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 378
2019 Revenue in Millions : 306
Growth (%) : 24

Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 317
2020 Revenue in Millions : 378
Growth (%) : -16

Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 164
2019 Revenue in Millions : 103
Growth (%) : 59

Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 215
2020 Revenue in Millions : 164
Growth (%) : 31

Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 414
2021 Revenue in Millions : 317
Growth (%) : 31

Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 218
2021 Revenue in Millions : 215
Growth (%) : 1

Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 266
2022 Revenue in Millions : 218
Growth (%) : 22

Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 312
2023 Revenue in Millions : 266
Growth (%) : 17

Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 119
2017 Revenue in Millions : 0
Growth (%) : New Launch

Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 306
2018 Revenue in Millions : 119
Growth (%) : 157

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Patents & EXCLUSIVITIES
ABOUT THIS PAGE